3 Reasons You Should Buy Canopy Growth Stock now

Drake’s partnership with Canopy Growth’s (TSX:WEED)(NYSE:CGC) coupled with its cash hoard is a sign of underlying value for the weed stock.

| More on:
A colourful firework display

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

After an abysmal quarter, weed stocks have been battered across the board. Industry leader Canopy Growth’s (TSX:WEED)(NYSE:CGC) stock has been hit the worst and is now trading at its lowest value since weed was legalized in 2017. 

Investor sentiment in this sector has clearly moved to extreme pessimism and with good reason. Growth and cash flow expectations have been dashed, as Canopy reported a loss of $374.6 million or $1.08 a share in its second quarter and net revenue declined 15% sequentially to $76.6 million –worrying signs for a “growth” stock. 

Unsurprisingly, the stock is down by double-digit percentages since the results were announced. However, I believe this recent plunge in the company’s valuation offers long-term investors a healthy point of entry. Canopy is likely to survive this current phase of turmoil and consolidation and come out on top.

Here are three reasons for my optimism. 

Low valuation to cash

The recent correction has made the valuation of weed stocks more realistic. Gone are the days when a cannabis producer could trade at hundreds of times revenue. Now, investors are much more skeptical and the valuations are more in line with fundamentals. 

In Canopy’s case, I believe the current valuation is falling below fundamentals. Let’s not forget that this company is backed by one of the world’s largest alcoholic beverage producers and has billions in cash on hand. $2.7 billion to be exact, according to its latest reports. 

At the moment, the stock is trading at 2.67 times this cash per share value, which indicates that investors have oversold. 

Path to profitability

Unlike its smaller and less resourceful rivals, Canopy has a path to profitability because of its cash hoard. That $2.7 billion is likely to keep the company funded for the next three years. Over three years, Canopy’s production facilities will be fully operational, the market price for its product will stabilize, and marketing expenses will moderate. 

In other words, Canopy doesn’t need to issue more shares or borrow external capital to keep operations going, as its smaller rivals fail and leave more space for the company to expand. I estimate that Canopy could be profitable by 2022

Emerging consumer brands

Canopy’s recent partnership with Drake is a clear indication that this company will dominate the consumer market for weed with exceptional brands.

Tweed and Tokyo Smoke are already emerging as recognized brands on social media. Martha Stewart, rapper Snoop Dogg, and actor Seth Rogan have already teamed up with Canopy, so adding the Toronto rap star is another partnership that adds immense value to Canopy’s brand portfolio. 

Over time, I expect these brands to create intangible value and a competitive advantage for the company that should help it cement its lead in the industry. 

Foolish takeaway

Betting on weed stocks isn’t for the faint of heart at the moment. The industry faces plenty of challenges. However, I believe none of these challenges are existential or insurmountable for Canopy. 

If my thesis is correct, long-term shareholders should see the current market price of Canopy’s stock as an excellent opportunity. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani has no position in any of the stocks mentioned. 

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »